Form 4 for TXG 10x Genomics, Inc.

Accepted 2022-09-16 00:00:00 ET · period of report 2022-09-14 · accession 0001567619-22-017565 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-09-16	2022-09-14	TXG	McAnear Justin J.	CFO	A - Grant	$0.00	+20.3K	78.4K	+35%	$0
DM	2022-09-16	2022-09-14	TXG	McAnear Justin J.	CFO	A - Grant	$0.00	+81.2K	40.6K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2022-09-14	A	A	20,297	$0.00	78,389	D	—	—	(F1) Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/16th of the RSUs vest on each quarterly anniversary measured from August 21, 2022, subject to the Reporting Person continuing as a service provider through each such date.
2	Derivative	Performance-based Restricted Stock Units	2022-09-14	A	A	40,593	$0.00	40,593	D	— · — to 2026-09-14	40,593 Class A Common Stock	(F3) Each Performance-Based Restricted Stock Unit ("PSU") represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/3rd of the PSUs vest upon the Issuer's Class A Common Stock achieving each of three escalating stock price milestones, subject to the Reporting Person continuing as a service provider through each such date.
3	Derivative	Stock Option (right to buy)	2022-09-14	A	A	40,593	$0.00	40,593	D	$33.67 · — to 2032-09-14	40,593 Class A Common Stock	(F2) 1/48th of the shares subject to the option vest on each monthly anniversary measured from September 14, 2022, subject to the Reporting Person continuing as a service provider through each such date.